Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971. (Q30807440)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971. |
scientific article |
Statements
Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971 (English)
M J B Taphoorn
J Menten
R Stupp
M Frenay
J M Kros
C C D van der Rijt
Ch J Vecht
A Allgeier
T Gorlia
European Organization for Research and Treatment of Cancer Brain Tumor Group